Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

View the 50 largest pharmaceutical companies in the world listings here

Boehringer Ingelheim

Boehringer Ingelheim

Rank: 18

Ingelheim am Rhein, Germany
www.boehringer-ingelheim.com

2020 Revenues ($USD) : $17,163,157,895
2020 Revenues (foreign currencies) : €19,566,000,000
2020 R&D spend : $3,245,614,035
2020 Number of Employees : 51,944
Fiscal Year End : 12/31/2020
Key People : Hubertus von Baumbach, chair of the Board of Managing Directors; Carinne Brouillon, member of the Board of Managing Directors with responsibility for the Human Pharma Business Unit; Dr. Michel Pairet, member of the Board of Managing Directors with responsibility for the Innovation Unit; Jean Scheftsik de Szolnok, member of the Board of Managing Directors with responsibility for the Animal Health Business Unit; Michael Schmelmer, member of the Board of Managing Directors with responsibility for Finance & Group Functions

Ingelheim, Germany–based Boehringer Ingelheim is the world’s largest private pharmaceutical company. Founded in 1885, Boehringer Ingelheim started out producing ingredients for baking powder and carbonated beverages. Now, Boehringer Ingelheim's core areas include making drugs to treat cardiovascular disease, oncology, respiratory problems, metabolic disease, immunology, retinal health and central nervous system disorders. Boehringer Ingelheim also has a large animal health business. In May, the company announced its acquisition of Northern Biologics, a maker of therapeutic antibodies. More acquisition announcements would follow, including its December announcement that it was buying Labor Dr. Merk & Kollegen to strengthen its immuno-oncology offerings. It also announced the $1.5 billion purchase of NBE Therapeutics, which has drug candidates for treating triple-negative breast cancer and lung cancer. –BB

Boehringer Ingelheim

Biopharmaceuticals production site in Fremont, Calif. Image courtesy of Boehringer Ingelheim.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50